AMGEN EUROPE PATENTS FACING OPPOSITIONS
Top patents of AMGEN EUROPE facing oppositions at the European Patent Office (EPO)
| Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
|---|---|---|---|---|---|
| EP2962690B1 | 16 Jan, 2019 | (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions Thereof | NA | 15 | |
| EP2797581B1 | 06 May, 2020 | Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione | Dec, 2032 | 3 | |
| EP2651400B2 | 18 Jan, 2023 | Controlled Release Oral Dosage Forms Of Poorly Soluble Drugs And Uses Thereof | NA | 1 | |
| EP3320902B1 | 17 Feb, 2021 | Methods For Treating Diseases Using Isoindoline Compounds | Mar, 2032 | 1 |